drugset / Trial / NCT04637529

Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain

NCT04637529

Phase 2 Completed 176 enrolled Apsen Farmaceutica S.A.
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of S (+) - ibuprofen compared to an active treatment for pain control in individuals diagnosed with osteoarthritis.

Timeline

Start
2022-08-05
Primary completion
2023-06-30
Completion
2023-06-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Ibuprofen Small molecule

Indications